Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data

Fig. 2

Genotype-phenotype atlas of hereditary breast cancer. A Germline pathogenic variants (GPVs) in BRCA1 were found in 131 (4.5%) patients. Most BRCA1 carriers had triple-negative breast cancer (82/131, 62.6%). B GPVs in BRCA2 were found in 134 (4.6%) patients. Most BRCA2 carriers were hormone receptor (HR)-positive and HER2-negative (90/134, 67.2%). C GPVs in PALB2 were found in 33 (1.1%) patients. Most PALB2 carriers were HR-positive and HER2-negative (21/33, 63.6%)

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us